Alsa-ec.org
Title
The ALS Association: Home
Description
Excerpted from the website:
- The ALS Association has awarded Cambria Biosciences a $3.5 million contract to develop new drug compounds for treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. This partnership builds on previously funded efforts with Cambria to develop unique neuroprotective drug compounds that prevent cell death caused by misfolded proteins that aggregate together within the cell. Mutant copper-zinc superoxide dismutase, or SOD1, is a protein that is misfolded to form aggregates in the motor neurons of some people with inherited forms of ALS.
Languages
English
Address
- 6627 S 191st Pl
- Kent WA 98032 US
Contact
- ALS Association Evergreen Chapter
-
- +1 425 656 1650
Additional Information
Related Domains
External Links
- Alexa: Alsa-ec.org
- WHOIS for Alsa-ec.org